Related references
Note: Only part of the references are listed.Efflux-Mediated Antifungal Drug Resistance
Richard D. Cannon et al.
CLINICAL MICROBIOLOGY REVIEWS (2009)
Suppression of anti-Candida activity of macrophages by a quorum-sensing molecule, farnesol, through induction of oxidative stress
Shigeru Abe et al.
MICROBIOLOGY AND IMMUNOLOGY (2009)
Differential susceptibility of mitogen-activated protein kinase pathway mutants to oxidative-mediated killing by phagocytes in the fungal pathogen Candida albicans
David M. Arana et al.
CELLULAR MICROBIOLOGY (2007)
Identification of promoter elements responsible for the regulation of MDR1 from Candida albicans, a major facilitator transporter involved in azole resistance
Benedicte Rognon et al.
MICROBIOLOGY-SGM (2006)
cDNA microarray analysis of differential gene expression and regulation in clinically drug-resistant isolates of Candida albicans from bone marrow transplanted patients
Zheng Xu et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2006)
Enhanced pathogenicity of Candida albicans pre-treated with subinhibitory concentrations of fluconazole in a mouse model of disseminated candidiasis
DHMLP Navarathna et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Candida albicans-conditioned medium protects yeast cells from oxidative stress:: a possible link between quorum sensing and oxidative stress resistance
C Westwater et al.
EUKARYOTIC CELL (2005)
Transcriptional response of Candida albicans to nitric oxide and the role of the YHB1 gene in nitrosative stress and virulence
BS Hromatka et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
Proteomic analysis of azole resistance in Candida albicans clinical isolates
MZ Hooshdaran et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Inducible defense mechanism against nitric oxide in Candida albicans
BD Ullmann et al.
EUKARYOTIC CELL (2004)
Gene expression in HL60 granulocytoids and human polymorphonuclear leukocytes exposed to Candida albicans
A Mullick et al.
INFECTION AND IMMUNITY (2004)
Enhanced production of farnesol by Candida albicans treated with four azoles
JM Hornby et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Calcineurin A of Candida albicans:: involvement in antifungal tolerance, cell morphogenesis and virulence
D Sanglard et al.
MOLECULAR MICROBIOLOGY (2003)
Genome-wide expression profile analysis reveals coordinately regulated genes associated with stepwise acquisition of azole resistance in Candida albicans clinical isolates
PD Rogers et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Thioredoxins are required for protection against a reductive stress in the yeast Saccharomyces cerevisiae
EW Trotter et al.
MOLECULAR MICROBIOLOGY (2002)
Endogenous reactive oxygen species is an important mediator of miconazole antifungal effect
D Kobayashi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Transcription initiation of genes associated with azole resistance in Candida albicans
JB Harry et al.
MEDICAL MYCOLOGY (2002)
Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000
MA Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
The Saccharomyces cerevisiae Sko1p transcription factor mediates HOG pathway-dependent osmotic regulation of a set of genes encoding enzymes implicated in protection from oxidative damage
M Rep et al.
MOLECULAR MICROBIOLOGY (2001)
Role of thioredoxin reductase in the Yap1p-dependent response to oxidative stress in Saccharomyces cerevisiae
O Carmel-Harel et al.
MOLECULAR MICROBIOLOGY (2001)
Upregulation of ERG genes in Candida species by azoles and other sterol biosynthesis inhibitors
KW Henry et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
